4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-167636
10% owner sold 426,005 shares at $40.32 ($17,175,244)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Third Rock Ventures V, L.P. · 10% owner
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-17 | Sale : show line 1 in the form 10b5-1 | −426,005 | $40.32 | $17,175,244 | 6,709,228 | D |
| Open-market sales · 426,005 sh · avg $40.32 · $17,175,244 | ||||||
Loading xslF345X06/ownership.xml…